Filing Details

Accession Number:
0001104659-16-122649
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-23 16:15:53
Reporting Period:
2016-05-20
Filing Date:
2016-05-23
Accepted Time:
2016-05-23 16:15:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1660719 Aralez Pharmaceuticals Inc. ARLZ () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1527710 Patrick James Tursi C/o Aralez Pharmaceuticals Inc.,
151 Steeles Avenue East
Milton, Ontario A6 L9T 1Y1
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, Without Par Value Acquisiton 2016-05-20 10,000 $3.75 179,368 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct